TrialEuropean journal of drug metabolism and pharmacokinetics2024
A Phase I Clinical Study Comparing the Pharmacokinetics, Safety, and Immunogenicity of GB221 Injection and Trastuzumab (Herceptin
Yu Zhu et al.PubMed ↗Publisher ↗
No numbers read from the abstract.